SCHEMBL7605656

SCHEMBL7605656

Cc1ccc2c(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)c3ccccc3c(-c3ccccc3)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
ATM Q13315 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KMT2A Q03164 2/20 0.41
AKR1C4 P17516 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
PTGS2 P35354 2/20 0.38
HDAC4 P56524 1/20 0.38
ACHE P22303 1/20 0.37
ALDH1A1 P00352 4/20 0.37
HTT P42858 3/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 1/20 0.37
GFER P55789 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CYP2C9 P11712 1/20 0.37
PDE9A O76083 1/20 0.36
PDE1C Q14123 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7605380 1.00 KDM4E (0.49) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL10098594 0.97 KDM4E (0.46) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL9914755 0.97 KDM4E (0.47) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL11954046 0.97 KDM4E (0.47) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL9890945 0.95 KDM4E (0.46) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL10098628 0.94 KDM4E (0.41) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL10098614 0.94 KDM4E (0.49) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL10098595 0.93 KDM4E (0.42) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL11910797 0.93 KDM4E (0.40) KDM4EATML3MBTL1KMT2AAKR1C4
SCHEMBL12893485 0.91 KDM4E (0.41) KDM4EATML3MBTL1KMT2AAKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-20120288620-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-11-15 US disclosed
US-20120288620-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-11-15 US disclosed
US-8298687-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-30 US disclosed
US-8298687-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-30 US disclosed
US-8231942-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-07-31 US disclosed
US-8231942-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-07-31 US disclosed
US-8039122-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-10-18 US disclosed
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-03 US disclosed
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-03 US disclosed
US-20090317539-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-12-24 US disclosed
US-20090317539-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-12-24 US disclosed
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-01-15 US disclosed
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-01-15 US disclosed
US-20080286445-A1 COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080286445-A1 COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 KDM4E 2175/4885ATM 527/4885L3MBTL1 3456/4885
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 KDM4E 2175/4885ATM 527/4885L3MBTL1 3456/4885
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device CRY1, CRY2, CYBA KDM4E 2566/4885ATM 729/4885L3MBTL1 3184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.